Article History
Received: 29 June 2023
Accepted: 24 August 2023
First Online: 9 October 2023
Declarations
:
: Arthur Esquer declares that he has no competing interests. Frédéric Blanc was the national coordinator for France for the Eisai Delphia (E2027), Axovant Headway-DLB and Roche Graduate clinical trials; he had received honoraria from Roche, Eisai, and Biogen for oral presentations, and from Eisai for a participation in a board meeting. Nicolas Collongues has received honoraria for consulting or presentation from Alexion, Biogen Idec, Bristol-Myers Squibb, Horizon Therapeutics, Merck Serono, Novartis, Roche and Sanofi-Genzyme and is a member of the Editorial Board of the Journal de la Ligue Française contre la Sclérose en plaques and the Neurology and Therapy Journal.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.